A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma

BACKGROUND: Nicotinamide adenine dinucleotide (NAD+) metabolism is involved in a series of cancer pathogenesis processes, and is considered a promising therapeutic target for cancer treatment. However, a comprehensive analysis of NAD+ metabolism events on immune regulation and cancer survival has no...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Cheng, Zhou, Yujie, Yan, Lizhao, Zheng, Jianglin, Wang, Xuan, Li, Junjun, Jiang, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945104/
https://www.ncbi.nlm.nih.gov/pubmed/36845744
http://dx.doi.org/10.3389/fonc.2023.1051641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945104/
https://www.ncbi.nlm.nih.gov/pubmed/36845744
http://dx.doi.org/10.3389/fonc.2023.1051641

Ejemplares similares